Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

InsuJet [is] the first device to Canada that actually has no needles,” said Daphne Lapenna of Sol-Millennium Medical Ltd. who ...

Insulet’s Omnipod 5 automated insulin delivery (AID) system has multiple avenues to expand as it has revolutionized the way patients treat their diabetes, including the new indication for Type 2 ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

A rogue B.C. acupuncturist has been found in contempt of court for practising unlicensed needlework. A B.C. Supreme Court ...

At a special awards ceremony held in the Diabetes Centre at Sligo University Hospital, on Tuesday, Diabetes Ireland honoured ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.

As we approach Thanksgiving at Mission Hospital McDowell, gratitude abounds for those who gave expertise, time and assistance ...

The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to Stelara ® (ustekinumab), expanding the product’s indications to include ...

Thursday is World Diabetes Day. Diabetes affects 40 million Americans and for most, the best form of treatment includes ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control ...